Prostate cancer with high serum level of CEA and CA19-9: a case report

  • MOMMA, Tetsuo
    the Department of Urology, the Second Tokyo National Hospital
  • KIMURA, Satoru
    the Department of Urology, the Second Tokyo National Hospital
  • SAITO, Shiro
    the Department of Urology, the Second Tokyo National Hospital
  • ONODA, Noboru
    the Department of Pathology, the Second Tokyo National Hospital

Bibliographic Information

Other Title
  • CEAとCA19-9が高値を示した前立腺癌の1例

Search this article

Description

We report a case of primary adenocarcinoma of the prostate cancer producing carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9). An 80-year-old man admitted to our hospital with the complaint of appetite loss. Serum CEA and CA19-9 levels were increased to 28.9 ng/ml (normal < 3.5) and 271 U/ml (normal < 37), respectively. Serum PSA level was also high (33 ng/ml; normal < 3.6). Computed tomography (CT) demonstrated para-aortic lymph node swelling and bone scan revealed multiple bone metastasis. Prostate biopsy was performed and the specimen showed no evidence of malignancy. However endocrine therapy was started because of the strong suspicion of prostate cancer. In spite of the treatment, the patient died 2 months after the treatment. Histology of autopsy specimen demonstrated primary prostate cancer (poorly differentiated adenocarcinoma) and metastases to multiple organs, such as lungs, liver, thyroid, bone marrow and adrenals. Immunohistochemical staining for CEA, CA19-9 and PSA demonstrated the existence of each protein at both primary and metastatic sites.

Journal

  • Hinyokika Kiyo

    Hinyokika Kiyo 44 (3), 187-191, 1998-03

    泌尿器科紀要刊行会

Citations (2)*help

See more

Details 詳細情報について

Report a problem

Back to top